Skip to main content
DuChemBio Co, LTD logo

DuChemBio Co, LTD — Investor Relations & Filings

Ticker · 176750 ISIN · KR7176750008 KO Manufacturing
Open in API
Filings indexed 291 across all filing types
Latest filing 2025-08-18 Report Publication Anno…
Country KR South Korea
Listing KO 176750

About DuChemBio Co, LTD

http://www.duchembio.com/en/

DuChemBio Co., Ltd. is a pharmaceutical company specializing in the development, manufacturing, and commercialization of radiopharmaceuticals. The company focuses on products for both diagnosis and treatment, with a primary emphasis on positron emission tomography (PET) imaging tracers. Its portfolio targets key therapeutic areas, including oncology for cancer detection and neurology for conditions such as Alzheimer's and Parkinson's disease. The company's mission is to develop novel radiopharmaceuticals and achieve successful commercialization on a global scale.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is an announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience, and purpose of the seminar. Since it is an announcement of an event rather than the presentation materials themselves, and it does not fit into other specific categories like earnings releases or financial reports, it is classified as a Regulatory Filing (RNS) as it serves as a formal notice to the market via the Korea Exchange (KIND system).
2025-08-18 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'DuChemBio' covering the period from 2025-01-01 to 2025-06-30. It contains detailed financial information, business descriptions, management discussions, and capital structure data. According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year (like a half-year report) containing actual financial statements and analysis is classified as an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience, and purpose of the seminar. Since it is an announcement of an event rather than the presentation slides themselves, and it is a regulatory notification filed via the Korea Exchange (KIND system), it falls under the category of a general regulatory announcement or notice of an event.
2025-08-11 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (Non-Deal Roadshow). It provides the date, location, purpose, and contact information for the event. It does not contain the actual presentation slides or financial report, but rather announces the event and the availability of materials on the KRX KIND system. Per the 'Menu vs Meal' rule, this is an announcement of an event/report, fitting the criteria for a Regulatory Filing (RNS) as it is a standard corporate disclosure of an event schedule.
2025-06-02 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding the scheduling and details of an upcoming Investor Relations (IR) event (a seminar on Alzheimer's disease). It provides the date, location, and purpose of the meeting, and mentions that IR materials are available on the Korea Exchange (KIND) system. Since this is an announcement of an event/presentation rather than the presentation itself, and it does not fit into specific categories like earnings releases or financial reports, it is classified as a Regulatory Filing (RNS).
2025-05-21 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'DuChemBio' (주식회사 듀켐바이오) covering the period from January 1, 2025, to March 31, 2025. It contains detailed corporate information, capital structure, management changes, and business descriptions, which are characteristic of a formal quarterly financial filing submitted to the Financial Supervisory Service (금융위원회) and the Korea Exchange (한국거래소). Q1 2025
2025-05-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.